GB1419788A
(en)
|
1972-08-02 |
1975-12-31 |
Pfizer |
Herbicidal method using 2-trifuluromethyl-4-quinolinols
|
WO1992000075A1
(en)
|
1990-06-29 |
1992-01-09 |
Pfizer Inc. |
Pyridopyrazine derivatives for treating substance abuse and addiction
|
NO179904C
(en)
|
1992-09-04 |
1997-01-08 |
Takeda Chemical Industries Ltd |
Condensed heterocyclic compounds and their use
|
EP1308461A3
(en)
|
1993-01-25 |
2004-02-11 |
Takeda Chemical Industries, Ltd. |
Antibodies to beta-amyloids or their derivatives and use thereof
|
TW394773B
(en)
|
1995-03-24 |
2000-06-21 |
Takeda Chemical Industries Ltd |
Cyclic compounds for antagonizing tachykinin receptor, substance p receptor and neurokinin a receptor, their production and pharmaceutical composition
|
DE19709877A1
(en)
|
1997-03-11 |
1998-09-17 |
Bayer Ag |
1,5-dihydro-pyrazolo [3,4-d] pyrimidinone derivatives
|
AU743827B2
(en)
|
1997-04-09 |
2002-02-07 |
Intellect Neurosciences, Inc. |
Recombinant antibodies specific for beta-amyloid ends, DNA encoding and methods of use thereof
|
US8173127B2
(en)
|
1997-04-09 |
2012-05-08 |
Intellect Neurosciences, Inc. |
Specific antibodies to amyloid beta peptide, pharmaceutical compositions and methods of use thereof
|
GB9722520D0
(en)
|
1997-10-24 |
1997-12-24 |
Pfizer Ltd |
Compounds
|
TWI239847B
(en)
|
1997-12-02 |
2005-09-21 |
Elan Pharm Inc |
N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease
|
US6743427B1
(en)
|
1997-12-02 |
2004-06-01 |
Neuralab Limited |
Prevention and treatment of amyloidogenic disease
|
DE69903715T2
(en)
|
1998-03-03 |
2003-08-14 |
Ppg Industries Ohio, Inc. |
Impregnated glass thread and products containing them
|
US20020132817A1
(en)
|
1998-03-19 |
2002-09-19 |
Hideaki Natsugari |
Heterocyclic compounds, their production and use
|
AU1409100A
(en)
|
1998-11-27 |
2000-06-19 |
Takeda Chemical Industries Ltd. |
Drugs
|
AU4178601A
(en)
|
2000-02-24 |
2001-09-03 |
Univ Washington |
Humanized antibodies that sequester abeta peptide
|
DE10045112A1
(en)
|
2000-09-11 |
2002-03-21 |
Merck Patent Gmbh |
Use of indole derivatives for the treatment of diseases of the central nervous system
|
CA2427661C
(en)
|
2000-11-03 |
2013-05-28 |
Proteotech, Inc. |
Methods of isolating amyloid-inhibiting compounds and use of compounds isolated from uncaria tomentosa and related plants
|
CA2451998A1
(en)
|
2001-08-17 |
2003-02-27 |
Eli Lilly And Company |
Anti-a.beta. antibodies
|
US20030195205A1
(en)
|
2001-11-02 |
2003-10-16 |
Pfizer Inc. |
PDE9 inhibitors for treating cardiovascular disorders
|
DE10238724A1
(en)
|
2002-08-23 |
2004-03-04 |
Bayer Ag |
New 6-alkyl-1,5-dihydro-4H-pyrazolo-(3,4-d)-pyrimidin-4-ones useful as selective phosphodiesterase 9A inhibitors for improving attention, concentration, learning and/or memory performance
|
DE10238723A1
(en)
|
2002-08-23 |
2004-03-11 |
Bayer Ag |
Phenyl substituted pyrazolyprimidines
|
JP2006506352A
(en)
|
2002-09-11 |
2006-02-23 |
メルク エンド カムパニー インコーポレーテッド |
Dihydroxypyridopyrazine-1,6-dione compounds useful as HIV integrase inhibitors
|
AU2003263518A1
(en)
|
2002-10-09 |
2004-05-04 |
Pfizer Products Inc. |
Pyrazole compounds for treatment of neurodegenerative disorders
|
PL377769A1
(en)
|
2002-10-09 |
2006-02-20 |
Rinat Neuroscience Corp. |
Methods of treating alzheimer's disease using antibodies directed against amyloid beta peptide and compositions thereof
|
WO2004035577A2
(en)
|
2002-10-16 |
2004-04-29 |
Gilead Sciences, Inc. |
Pre-organized tricyclic integrase inhibitor compounds
|
US20040220186A1
(en)
|
2003-04-30 |
2004-11-04 |
Pfizer Inc. |
PDE9 inhibitors for treating type 2 diabetes,metabolic syndrome, and cardiovascular disease
|
EP1638935A1
(en)
|
2003-06-19 |
2006-03-29 |
Pfizer Products Inc. |
Nk1 antagonist
|
MXPA06001845A
(en)
|
2003-08-21 |
2006-05-04 |
Pfizer Prod Inc |
Compounds for the treatment of neurodegenerative disorders.
|
US20070031416A1
(en)
|
2003-09-09 |
2007-02-08 |
Takeda Pharmaceutical Company Limited |
Use of antibody
|
US7572799B2
(en)
|
2003-11-24 |
2009-08-11 |
Pfizer Inc |
Pyrazolo[4,3-d]pyrimidines as Phosphodiesterase Inhibitors
|
GB0327319D0
(en)
|
2003-11-24 |
2003-12-24 |
Pfizer Ltd |
Novel pharmaceuticals
|
US20070155731A1
(en)
|
2004-01-28 |
2007-07-05 |
Gabor Butora |
Aminocyclopentyl pyridopyrazinone modulators of chemokine receptor activity
|
BRPI0507374A
(en)
|
2004-02-02 |
2007-07-10 |
Pfizer Prod Inc |
histamine-3 receptor modulators
|
US7820680B2
(en)
|
2004-03-09 |
2010-10-26 |
Merck & Co., Inc. |
HIV integrase inhibitors
|
AP2379A
(en)
|
2004-03-23 |
2012-03-08 |
Pfizer Prod Inc |
Imidazole compounds for the treatment of neurodegenerative disorders.
|
DK1742642T3
(en)
|
2004-04-14 |
2009-02-16 |
Gilead Sciences Inc |
Phosphonate analogues of HIV integrase inhibitor compounds
|
US7456164B2
(en)
|
2004-05-07 |
2008-11-25 |
Pfizer, Inc |
3- or 4-monosubtituted phenol and thiophenol derivatives useful as H3 ligands
|
EP1595881A1
(en)
|
2004-05-12 |
2005-11-16 |
Pfizer Limited |
Tetrahydronaphthyridine derivates useful as histamine H3 receptor ligands
|
SG190665A1
(en)
|
2004-07-30 |
2013-06-28 |
Rinat Neuroscience Corp |
Antibodies directed against amyloid-beta peptide and methods using same
|
FR2877015B1
(en)
|
2004-10-21 |
2007-10-26 |
Commissariat Energie Atomique |
NANOSTRUCTURE COATING AND COATING PROCESS.
|
GB0423356D0
(en)
|
2004-10-21 |
2004-11-24 |
Merck Sharp & Dohme |
Therapeutic agents
|
EP1827493A4
(en)
|
2004-12-22 |
2009-09-30 |
Univ St Louis |
Use of anti-abeta antibody to treat traumatic brain injury
|
MY148086A
(en)
|
2005-04-29 |
2013-02-28 |
Rinat Neuroscience Corp |
Antibodies directed against amyloid-beta peptide and methods using same
|
US7741315B2
(en)
|
2005-05-10 |
2010-06-22 |
Merck Sharp & Dohme Corp. |
HIV integrase inhibitors
|
CA2608018C
(en)
|
2005-05-12 |
2010-07-13 |
Pfizer Inc. |
Anhydrous crystalline forms of n-[1-(2-ethoxyethyl)-5-(n-ethyl-n-methylamino)-7-(4-methylpyridin-2-yl-amino)-1h-pyrazolo[4,3-d]pyrimidine-3-carbonyl]methanesulfonamide
|
CA2603830A1
(en)
|
2005-05-24 |
2006-11-30 |
Pharmacia & Upjohn Co Llc |
Pyridino [2 , 3-b] pyrazinones as pde-5 inhibitors
|
CA2608672A1
(en)
|
2005-05-24 |
2006-11-30 |
Pharmacia & Upjohn Company Llc |
Pyridine [3,4-b] pyrazinones as pde-5 inhibitors
|
WO2006126083A1
(en)
|
2005-05-24 |
2006-11-30 |
Pharmacia & Upjohn Company Llc |
Pyridine [3 , 4-b] pyrazinone compounds as pde-5 inhibitors
|
ATE488496T1
(en)
|
2005-06-22 |
2010-12-15 |
Pfizer Prod Inc |
HISTAMINE 3 RECEPTOR ANTAGONISTS
|
US20070060534A1
(en)
|
2005-06-30 |
2007-03-15 |
Threshold Pharmaceuticals, Inc. |
Anthracycline analogs
|
US8158673B2
(en)
|
2005-10-27 |
2012-04-17 |
Pfizer Inc. |
Histamine-3 receptor antagonists
|
CA2624625A1
(en)
|
2005-11-04 |
2007-05-10 |
Pfizer Limited |
Tetrahydronaphthyridine derivative
|
JP2009516703A
(en)
|
2005-11-18 |
2009-04-23 |
グラクソ グループ リミテッド |
New intermediates and their use
|
EP1948614A2
(en)
|
2005-11-18 |
2008-07-30 |
Takeda San Diego, Inc. |
Glucokinase activators
|
MY144960A
(en)
|
2005-11-24 |
2011-11-30 |
Eisai R&D Man Co Ltd |
Morpholine type cinnamide compound
|
US20070117839A1
(en)
|
2005-11-24 |
2007-05-24 |
Eisai R&D Management Co., Ltd. |
Two cyclic cinnamide compound
|
WO2007063385A2
(en)
|
2005-12-01 |
2007-06-07 |
Pfizer Products Inc. |
Spirocyclic amine histamine-3 receptor antagonists
|
WO2007069053A1
(en)
|
2005-12-14 |
2007-06-21 |
Pfizer Products Inc. |
Benzimidazole antagonists of the h-3 receptor
|
WO2007084595A2
(en)
*
|
2006-01-20 |
2007-07-26 |
Schering Corporation |
Carbocyclic and heterocyclic arylsulfones as gamma secretase inhibitors
|
WO2007088462A1
(en)
|
2006-02-01 |
2007-08-09 |
Pfizer Products Inc. |
Spirochromane antagonists of the h-3 receptor
|
WO2007088450A2
(en)
|
2006-02-01 |
2007-08-09 |
Pfizer Products Inc. |
Chromane antagonist of the h-3 receptor
|
WO2007099423A1
(en)
|
2006-03-02 |
2007-09-07 |
Pfizer Products Inc. |
1-pyrrolidine indane derivatives as histamine-3 receptor antagonists
|
TWI378091B
(en)
|
2006-03-09 |
2012-12-01 |
Eisai R&D Man Co Ltd |
Multi-cyclic cinnamide derivatives
|
US20090163482A1
(en)
|
2006-03-13 |
2009-06-25 |
Mchardy Stanton Furst |
Tetralines antagonists of the h-3 receptor
|
AP2408A
(en)
|
2006-04-21 |
2012-05-30 |
Pfizer Prod Inc |
Pyridine[3,4-B]pyrazinones.
|
WO2007136573A2
(en)
|
2006-05-15 |
2007-11-29 |
Merck & Co., Inc. |
Antidiabetic bicyclic compounds
|
US20090306054A1
(en)
|
2006-05-16 |
2009-12-10 |
Gilead Sciences ,Inc. |
Integrase inhibitors
|
KR20090018963A
(en)
|
2006-05-19 |
2009-02-24 |
에자이 알앤드디 매니지먼트 가부시키가이샤 |
Urea type cinnamide derivative
|
WO2007138431A2
(en)
|
2006-05-30 |
2007-12-06 |
Pfizer Products Inc. |
Azabicyclic ether histamine-3 antagonists
|
MX2009007782A
(en)
|
2007-01-22 |
2009-07-31 |
Pfizer Prod Inc |
Tosylate salt of a therapeutic compound and pharmaceutical compositions thereof.
|
JP2010518083A
(en)
|
2007-02-12 |
2010-05-27 |
メルク・シャープ・エンド・ドーム・コーポレイション |
Piperidine derivatives
|
WO2008099210A2
(en)
|
2007-02-12 |
2008-08-21 |
Merck & Co., Inc. |
Piperazine derivatives for treatment of ad and related conditions
|
PE20081791A1
(en)
|
2007-02-28 |
2009-02-07 |
Eisai Randd Man Co Ltd |
TWO CYCLIC DERIVATIVES OF OXOMORPHOLIN
|
WO2008137102A2
(en)
|
2007-05-04 |
2008-11-13 |
Torreypines Therapeutics, Inc. |
Methods of modulating amyloid beta and compounds useful therefor
|
CN101809019A
(en)
|
2007-05-07 |
2010-08-18 |
先灵公司 |
Gamma secretase modulators
|
CN101675045B
(en)
|
2007-05-11 |
2012-11-28 |
弗·哈夫曼-拉罗切有限公司 |
Hetarylanilines as modulators for amyloid beta
|
TW200908968A
(en)
|
2007-05-29 |
2009-03-01 |
Sgx Pharmaceuticals Inc |
Substituted pyrrolopyridines and pyrazolopyridines as kinase modulators
|
EP2152695A2
(en)
|
2007-06-01 |
2010-02-17 |
Schering Corporation |
Gamma secretase modulators
|
MX2009013130A
(en)
|
2007-06-01 |
2010-01-15 |
Schering Corp |
Gamma secretase modulators.
|
US8242150B2
(en)
|
2007-06-13 |
2012-08-14 |
Merck Sharp & Dohme Corp. |
Triazole derivatives for treating alzheimer'S disease and related conditions
|
CA2692253A1
(en)
|
2007-06-29 |
2009-01-08 |
Schering Corporation |
Gamma secretase modulators
|
JP2010535762A
(en)
|
2007-08-06 |
2010-11-25 |
シェーリング コーポレイション |
Gamma secretase modulator
|
US7935815B2
(en)
|
2007-08-31 |
2011-05-03 |
Eisai R&D Management Co., Ltd. |
Imidazoyl pyridine compounds and salts thereof
|
US9453000B2
(en)
|
2007-08-31 |
2016-09-27 |
Eisai R&D Management Co., Ltd. |
Polycyclic compound
|
JP2010538068A
(en)
|
2007-09-06 |
2010-12-09 |
シェーリング コーポレイション |
Gamma secretase modulator
|
MX2010003397A
(en)
|
2007-09-28 |
2010-04-09 |
Schering Corp |
Gamma secretase modulators.
|
GB0720444D0
(en)
|
2007-10-18 |
2007-11-28 |
Glaxo Group Ltd |
Novel compounds
|
MX2010005028A
(en)
|
2007-11-05 |
2010-05-27 |
Schering Corp |
Gamma secretase modulators.
|
CA2707722A1
(en)
|
2007-12-06 |
2009-06-11 |
Schering Corporation |
Gamma secretase modulators
|
JP2011506461A
(en)
|
2007-12-11 |
2011-03-03 |
シェーリング コーポレイション |
γ-secretase modulator
|
EP2268636A1
(en)
|
2007-12-11 |
2011-01-05 |
Schering Corporation |
Gamma secretase modulators
|
CN101896461A
(en)
|
2007-12-13 |
2010-11-24 |
安姆根有限公司 |
Gamma secretase modulators
|
BRPI0906799A2
(en)
|
2008-01-11 |
2015-07-14 |
Hoffmann La Roche |
Beta Amyloid Modulators
|
EP2257541B1
(en)
|
2008-02-22 |
2013-08-14 |
F. Hoffmann-La Roche AG |
Modulators for amyloid beta
|
US20100137320A1
(en)
|
2008-02-29 |
2010-06-03 |
Schering Corporation |
Gamma secretase modulators
|
US20110027264A1
(en)
|
2008-02-29 |
2011-02-03 |
Xianhai Huang |
Gamma secretase modulators for the treatment of alzheimer's disease
|
EP2300427A1
(en)
|
2008-05-05 |
2011-03-30 |
Amgen Inc. |
Urea compounds as gamma secretase modulators
|
FR2933700B1
(en)
*
|
2008-07-08 |
2010-07-30 |
Sanofi Aventis |
PYRIDINO-PYRIDINONE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
|
TW201006801A
(en)
|
2008-07-18 |
2010-02-16 |
Lilly Co Eli |
Imidazole carboxamides
|
US8685972B2
(en)
|
2008-08-13 |
2014-04-01 |
Merck Sharp & Dohme Corp. |
Pyrimidine derivatives for treatment of alzheimer's disease
|
US20110251172A1
(en)
|
2008-08-13 |
2011-10-13 |
Rivkin Alexey A |
Purine derivatives for treatment of alzheimer's disease
|
BRPI0917144A2
(en)
|
2008-08-27 |
2015-08-04 |
Eisai R&D Man Co Ltd |
Process for preparing compounds, process for preparing a mixture, d-dbta, d-dpta and (+) -n- (1-phenylethyl) phthalamic acid ((+) -epepa) salts, and, compound.
|
BRPI0920651A2
(en)
|
2008-10-09 |
2016-01-12 |
Hoffmann La Roche |
beta amyloid modulators
|
CA2742602A1
(en)
|
2008-11-06 |
2010-05-14 |
Schering Corporation |
Gamma secretase modulators
|
CA2742500A1
(en)
|
2008-11-06 |
2010-05-14 |
Schering Corporation |
Gamma secretase modulators
|
MX2011004680A
(en)
|
2008-11-06 |
2011-05-25 |
Astrazeneca Ab |
Modulators of amyloid beta.
|
EP2355817A1
(en)
|
2008-11-10 |
2011-08-17 |
F. Hoffmann-La Roche AG |
Heterocyclic gamma secretase modulators
|
EP2379075A4
(en)
|
2008-12-16 |
2012-05-30 |
Merck Sharp & Dohme |
Triazole derivatives for treatment of alzheimer's disease
|
US8575150B2
(en)
|
2008-12-16 |
2013-11-05 |
Merck Sharp & Dohme Corp. |
Triazole derivatives for treatment of Alzheimer's disease
|
PA8854101A1
(en)
|
2008-12-18 |
2010-07-27 |
Ortho Mcneil Janssen Pharm |
IMIDAZOL BICYCLIC DERIVATIVES REPLACED AS MODULATORS OF GAMMA SECRETASA
|
AU2009327127C1
(en)
|
2008-12-19 |
2017-03-09 |
Centrexion Therapeutics Corporation |
Cyclic pyrimidin-4-carboxamides as CCR2 receptor antagonists for treatment of inflammation, asthma and COPD
|
EP2379566A2
(en)
|
2008-12-22 |
2011-10-26 |
Schering Corporation |
Gamma secretase modulators
|
CA2747744A1
(en)
|
2008-12-22 |
2010-07-01 |
Theodros Asberom |
Gamma secretase modulators
|
TW201030002A
(en)
|
2009-01-16 |
2010-08-16 |
Bristol Myers Squibb Co |
Bicyclic compounds for the reduction of beta-amyloid production
|
AU2010211109B2
(en)
|
2009-02-06 |
2014-11-27 |
Cellzome Limited |
Novel substituted bicyclic heterocyclic compounds as gamma secretase modulators
|
TWI461425B
(en)
|
2009-02-19 |
2014-11-21 |
Janssen Pharmaceuticals Inc |
Novel substituted benzoxazole, benzimidazole, oxazolopyridine and imidazopyridine derivatives as gamma secretase modulators
|
JP2012051806A
(en)
|
2009-02-26 |
2012-03-15 |
Eisai R & D Management Co Ltd |
Imidazolylpyrazine derivative
|
CN102333778B
(en)
|
2009-02-26 |
2015-05-13 |
卫材R&D管理有限公司 |
Salt of tetrahydrotriazolopyridine derivative and crystal thereof
|
JP2012051807A
(en)
|
2009-02-26 |
2012-03-15 |
Eisai R & D Management Co Ltd |
Arylimidazole compound
|
JP2012051805A
(en)
|
2009-02-26 |
2012-03-15 |
Eisai R & D Management Co Ltd |
Method for producing tetrahydrotriazolopyridine derivative
|
JP2012121809A
(en)
|
2009-02-26 |
2012-06-28 |
Eisai R & D Management Co Ltd |
Method for producing polycyclic compound and intermediate thereof
|
US20120053165A1
(en)
|
2009-03-03 |
2012-03-01 |
Pfizer Inc. |
Novel Phenyl Imidazoles and Phenyl Triazoles As Gamma-Secretase Modulators
|
NZ597597A
(en)
|
2009-08-07 |
2014-01-31 |
Dow Agrosciences Llc |
Pesticidal compositions containing heteroaryl-n-aryl carbamate compounds
|
WO2011048525A1
(en)
*
|
2009-10-20 |
2011-04-28 |
Pfizer Inc. |
Novel heteroaryl imidazoles and heteroaryl triazoles as gamma-secretase modulators
|
JP5721187B2
(en)
*
|
2009-12-22 |
2015-05-20 |
バーテックス ファーマシューティカルズ インコーポレイテッドVertex Pharmaceuticals Incorporated |
Isoindolinone inhibitor of phosphatidylinositol 3-kinase
|
JP5767393B2
(en)
|
2011-03-31 |
2015-08-19 |
ファイザー・インク |
New bicyclic pyridinone
|
US9181245B2
(en)
|
2012-05-16 |
2015-11-10 |
Janssen Pharmaceuticals, Inc. |
Substituted pyrido[1,2-a]pyrazines and substituted pyrido[1,2-a][1,4]diazepines for the treatment of (inter alia) Alzheimer's disease
|
TWI614238B
(en)
|
2012-09-21 |
2018-02-11 |
必治妥美雅史谷比公司 |
Bis(fluoroalkyl)-1,4-benzodiazepinone compounds and prodrugs thereof
|
UA110688C2
(en)
|
2012-09-21 |
2016-01-25 |
Пфайзер Інк. |
Bicyclic pirydynony
|
WO2014096212A1
(en)
|
2012-12-20 |
2014-06-26 |
Janssen Pharmaceutica Nv |
NOVEL TRICYCLIC 3,4-DIHYDRO-2H-PYRIDO[1,2-α]PYRAZINE-1,6-DIONE DERIVATIVES AS GAMMA SECRETASE MODULATORS
|
KR102171710B1
(en)
|
2013-01-17 |
2020-10-30 |
얀센 파마슈티카 엔.브이. |
Novel substituted pyrido-piperazinone derivatives as gamma secretase modulators
|
WO2015049616A1
(en)
|
2013-10-04 |
2015-04-09 |
Pfizer Inc. |
Novel bicyclic pyridinones as gamma-secretase modulators
|
CN111772834B
(en)
|
2014-03-21 |
2022-07-15 |
阿莱恩技术有限公司 |
Segmented orthodontic appliances with elastics
|
AU2015242330B2
(en)
|
2014-04-01 |
2017-08-17 |
Pfizer Inc. |
Chromene and 1,1 a,2,7b-tetrahydrocyclopropa[c]chromene pyridopyrazinediones as gamma-secretase modulators
|